Suppr超能文献

用于治疗角膜穿孔和疑难角膜疾病的组织粘合剂。

Tissue Adhesives for the Management of Corneal Perforations and Challenging Corneal Conditions.

作者信息

Sharma Ashok, Sharma Namrata, Basu Sayan, Sharma Rajan, Aggarwal Shruti, Gupta Parul Chawla, Ram Jagat, Nirankari Verinder S

机构信息

Dr Ashok Sharma Cornea Centre, Chandigarh, UT, India.

Cornea Service, Dr. R. P. Centre, AIIMS, New Delhi, India.

出版信息

Clin Ophthalmol. 2023 Jan 15;17:209-223. doi: 10.2147/OPTH.S394454. eCollection 2023.

Abstract

Corneal perforations are ophthalmological emergencies which can have serious and detrimental consequences, if not managed timely and appropriately. These are a significant cause of ocular morbidity and can result in decreased vision, blindness, and even loss of the eye. Corneal perforations can be managed using a range of treatment approaches, including temporary solutions such as the application of corneal glue and bandage contact lens, as well as definitive treatment such as corneal transplantation. Tissue glues/adhesives were developed as substitutes for sutures in ophthalmic surgery. Unlike sutures, these glues are associated with shorter overall surgical times and reduced inflammation, thus improving postoperative comfort without compromising wound strength. The available tissue adhesives can be broadly classified into two types: synthetic (eg, cyanoacrylate derivatives) and biological (eg, fibrin glue). Cyanoacrylate glue is chiefly used as a corneal patch to manage acute corneal perforations and improve visual outcomes. Fibrin glue can be used instead of cyanoacrylate glue in many conditions with the benefits of reduced conjunctival and corneal inflammation and reaction. Apart from this, each type of adhesive is distinct in terms of its benefits as well as limitations and is accordingly used for different indications. The present review focuses on the two main types of tissue adhesives, their applications in the management of corneal perforations, the associated complications, safety and efficacy data related to their use available in the literature and the need for newer adhesives in this field.

摘要

角膜穿孔是眼科急症,如果不及时、恰当地处理,可能会产生严重且有害的后果。这些是导致眼部发病的重要原因,可导致视力下降、失明,甚至眼球丧失。角膜穿孔可以采用一系列治疗方法进行处理,包括临时解决方案,如应用角膜胶水和绷带式隐形眼镜,以及确定性治疗,如角膜移植。组织胶水/黏合剂是作为眼科手术中缝线的替代品而开发的。与缝线不同,这些胶水可缩短总体手术时间并减轻炎症,从而在不影响伤口强度的情况下提高术后舒适度。现有的组织黏合剂大致可分为两类:合成类(如氰基丙烯酸酯衍生物)和生物类(如纤维蛋白胶)。氰基丙烯酸酯胶水主要用作角膜补片来处理急性角膜穿孔并改善视觉效果。在许多情况下,纤维蛋白胶可以替代氰基丙烯酸酯胶水使用,其优点是可减轻结膜和角膜的炎症及反应。除此之外,每种黏合剂在其优点和局限性方面都有所不同,因此用于不同的适应症。本综述重点关注两种主要类型的组织黏合剂、它们在角膜穿孔处理中的应用、相关并发症、文献中与它们使用相关的安全性和有效性数据,以及该领域对新型黏合剂的需求。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ade/9851054/11839a49edba/OPTH-17-209-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验